EULARACR

EULARACR refers to the collaborative initiatives between the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). The partnership is commonly cited as EULAR/ACR and is focused on developing consensus criteria, guidelines, and educational resources for rheumatic diseases. It brings together European and North American expertise to standardize research and clinical practice.

Historically, the most visible output of EULARACR is the development of classification criteria for rheumatoid arthritis (RA), notably the 2010 ACR/EULAR RA classification criteria. Since then, the two organizations have co-authored recommendations and guidelines for the management of RA and related conditions, including treatment strategies, monitoring, and the use of disease-modifying antirheumatic drugs (DMARDs). The collaboration also extends to other rheumatic diseases and to broader efforts in education, research collaboration, and the harmonization of outcome measures.

The impact of EULARACR lies in its influence on international research standards and clinical practice. Joint task forces publish guidance in major rheumatology journals and at international conferences, helping clinicians classify diseases consistently and apply evidence-based management approaches across diverse healthcare settings.

See also: European League Against Rheumatism, American College of Rheumatology, rheumatoid arthritis, rheumatology guidelines, EULAR guidelines, ACR guidelines.

Note: EULARACR denotes a collaborative framework rather than a separate, standalone organization. It encompasses joint statements, criteria, and recommendations produced through the partnership of EULAR and ACR.